XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.1
UNAUDITED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Total Global Payments Shareholders’ Equity
Number of Shares
Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Nonredeemable Noncontrolling Interests
Total Equity
Balance at beginning of period (in shares) at Dec. 31, 2023     260,383,000          
Balance at beginning of period at Dec. 31, 2023   $ 22,999,210   $ 19,800,953 $ 3,457,182 $ (258,925) $ 280,340 $ 23,279,550
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ 323,062 313,307     313,307   7,693 321,000
Other comprehensive income (loss) $ (61,600) (38,513)       (38,513) (15,001) (53,514)
Stock issued under share-based compensation plans (in shares)     1,132,000          
Stock issued under share-based compensation plans   11,031   11,031       11,031
Common stock repurchased - share-based compensation plans (in shares)     (322,000)          
Common stock repurchased - share-based compensation plans   (42,663)   (42,663)       (42,663)
Share-based compensation expense   40,117   40,117       40,117
Repurchase of common stock (in shares) (6,061,999)   (6,062,000)          
Repurchases of common stock $ (808,400) (808,365)   (808,365)       (808,365)
Distributions to noncontrolling interests             (4,748) (4,748)
Contributions from noncontrolling interests             89 89
Reclassification of redeemable noncontrolling interest to nonredeemable noncontrolling interest             358,872 358,872
Purchase of capped calls related to issuance of convertible notes, net of taxes   (194,677)   (194,677)       (194,677)
Cash dividends declared   (63,616)     (63,616)     (63,616)
Balance at end of period (in shares) at Mar. 31, 2024     255,131,000          
Balance at end of period at Mar. 31, 2024   22,215,831   18,806,396 3,706,873 (297,438) 627,245 22,843,076
Beginning balance at Dec. 31, 2023 507,965              
Redeemable Noncontrolling Interests                
Net income 2,062              
Other comprehensive income (8,086)              
Redeemable noncontrolling interests measurement period adjustment (358,872)              
Ending balance at Mar. 31, 2024 143,069              
Balance at beginning of period (in shares) at Dec. 31, 2024     248,709,000          
Balance at beginning of period at Dec. 31, 2024 22,855,944 22,280,686   18,118,942 4,774,736 (612,992) 575,258 22,855,944
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 312,772 305,734     305,734   8,224 313,958
Other comprehensive income (loss) $ 206,984 163,346       163,346 36,284 199,630
Stock issued under share-based compensation plans (in shares)     1,229,000          
Stock issued under share-based compensation plans   6,340   6,340       6,340
Common stock repurchased - share-based compensation plans (in shares)     (358,000)          
Common stock repurchased - share-based compensation plans   (37,342)   (37,342)       (37,342)
Share-based compensation expense   39,740   39,740       39,740
Repurchase of common stock (in shares) (4,218,350)   (4,218,000)          
Repurchases of common stock $ (449,000) (449,037)   (449,037)       (449,037)
Distributions to noncontrolling interests             (10,327) (10,327)
Cash dividends declared   (61,124)     (61,124)     (61,124)
Balance at end of period (in shares) at Mar. 31, 2025     245,362,000          
Balance at end of period at Mar. 31, 2025 22,857,782 $ 22,248,343   $ 17,678,643 $ 5,019,346 $ (449,646) $ 609,439 $ 22,857,782
Beginning balance at Dec. 31, 2024 160,623              
Redeemable Noncontrolling Interests                
Net income (1,186)              
Other comprehensive income 7,354              
Ending balance at Mar. 31, 2025 $ 166,791